MARK F MEHLER, MD
Neurology at Pelham Pkwy, Bronx, NY
License number
New York 152672
Category
Neurology
Type
Neurology
Address
Address
1410 Pelham Pkwy SOUTH ROOM 401, Bronx, NY 10461
Phone
(718) 430-3543
(718) 918-7505 (Fax)
(718) 918-7505 (Fax)
Professional information
Mark F Mehler, Bronx NY
Specialties:
Neurologist
Address:
111 E 210Th St, Bronx, NY 10467
1410 Pelham Pkwy S, Bronx, NY 10461
1410 Pelham Pkwy S, Bronx, NY 10461
Education:
Yeshiva University, Albert Einstein College of Medicine - Doctor of Medicine
Montefiore Medical Center - Fellowship - Biological Chemistry
Montefiore Medical Center - Residency - Neurology
Montefiore Medical Center - Fellowship - Biological Chemistry
Montefiore Medical Center - Residency - Neurology
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Mark F Mehler, Bronx NY
Specialties:
Neurology
Work:
Yeshiva University
1410 Pelham Pkwy S, Bronx, NY 10461
1410 Pelham Pkwy S, Bronx, NY 10461
Education:
Yeshiva University (1980)
Dr. Mark F Mehler, Bronx NY - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
MARK MEHLER MD
1410 Pelham Pkwy S STE K401, Bronx 10461
(718) 430-3543 (Phone), (718) 918-7505 (Fax)
1410 Pelham Pkwy S STE K401, Bronx 10461
(718) 430-3543 (Phone), (718) 918-7505 (Fax)
Certifications:
Neurology, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1980
Beth Israel-Harvard Med
Albert Einstein Coll Med
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1980
Beth Israel-Harvard Med
Albert Einstein Coll Med
Treatment Of Autism Spectrum Disorders With Agents That Activate The Locus Coeruleus - Noradrenergic System
US Patent:
2010013, May 27, 2010
Filed:
Oct 29, 2009
Appl. No.:
12/589854
Inventors:
Dominick P. Purpura - New York NY, US
Mark F. Mehler - Riverdale NY, US
Mark F. Mehler - Riverdale NY, US
International Classification:
A61K 31/433, A61K 31/137, A61K 31/335
US Classification:
514362, 514653, 514450
Abstract:
Methods are provided for treating autism spectrum disorders (ASD) using agents that activate the locus coeruleus-noradrenergic (LC-NA) system of the brain and for screening for compounds for treating ASD comprising determining whether or not the compounds activate the LC-NA system.